Author information from the last article
Tor Audun Hervig er spesialist i immunologi og transfusjonsmedisin og professor emeritus ved Universitetet i Bergen.
Articles by Tor Audun Hervig
Clinical Transfusion Handbook updated
- Tor Audun Hervig,
- Mirjana Grujic Arsenovic,
- Çiğdem Akalin Akkök,
- Barbora Jacobsen
18.06.2026:
The new edition of the handbook has been published on the metodebok.no portal. Transfusion medicine and blood transfusion are essential in patient care, including in the treatment of cancer, haematopoietic stem cell transplantation, solid organ transplantation and severe haemorrhage. Without...
Convalescent plasma from Norwegian blood donors to treat COVID-19
- Lise Sofie Haug Nissen-Meyer,
- Tine Torsvik Steinsvåg,
- Mona Høysæter Fenstad,
- Ingvild Hausberg Sørvoll,
- Marte Hvalryg,
- Thomas Larsen Titze,
- Karin Magnussen,
- Gunn Kristoffersen,
- Kathrine Margrethe Neuman Johnsen,
- Abid Hussain Llohn,
- Brita Hermundstad,
- Lilja Synnøve Høiback,
- Morten Haugen,
- Einar K. Kristoffersen,
- Line Boulland,
- Anne-Marte Bakken Kran,
- Fridtjof Lund-Johansen,
- John Torgils Vaage,
- Øystein Flesland,
- Tor Audun Hervig
03.08.2023:
Convalescent plasma for the treatment of COVID-19 is a blood component from a donor who has recovered from COVID-19. Despite uncertainty about its efficacy, many countries, including Norway, initiated the collection and use of COVID-19 convalescent plasma. The set-up and background of the Norwegian...
COVID-19 patients treated with convalescent plasma
- Lise Sofie Haug Nissen-Meyer,
- Magnhild Eide Macpherson,
- Linda Gail Skeie,
- Marte Hvalryg,
- Abid Hussain Llohn,
- Tine Torsvik Steinsvåg,
- Mona Høysæter Fenstad,
- Anders Tveita,
- Einar K. Kristoffersen,
- Tatjana Sundic,
- Fridtjof Lund-Johansen,
- John Torgils Vaage,
- Øystein Flesland,
- Anne Ma Dyrhol-Riise,
- Jan Cato Holter,
- Tor Audun Hervig,
- Børre Fevang
03.08.2023:
COVID-19 convalescent plasma (NORPLASMA) (1) first became available to Norwegian patients in the spring of 2020. The Norwegian Directorate of Health recommended use of the product in patients who were at risk of developing a severe/life-threatening course of COVID-19, where the attending doctor...